Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
9.29
+0.01 (0.11%)
Jul 16, 2025, 10:44 AM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Liver Disease | 235.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Liver Disease Growth | 30.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Cerebrovascular | 165.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular and Cerebrovascular Growth | -13.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antibacterial | 151.73M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antibacterial Growth | 80.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gout | 92.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gout Growth | 28.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fees for Technical Services | 34.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Fees for Technical Services Growth | 9.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prostaglandin | 26.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Prostaglandin Growth | 38.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nervous System | 12.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nervous System Growth | -89.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High-end Fluorine | 2.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
High-end Fluorine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-tumor | 1.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-tumor Growth | -33.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 94.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 64.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory System | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Respiratory System Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
International | 498.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 13.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 318.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -2.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|